[ad_1]
“The first 2-3 million doses of the Oxford-Irbm-AstraZeneca Covid vaccine should arrive in Italy by the end of November if the ongoing trial progresses positively, after temporary suspension due to a suspicious reaction in a volunteer then it turned out no be related to the candidate vaccine “. Piero di Lorenzo, president of the Irbm of Pomezia, confirmed that the research work continues to advance, the volunteer had been affected by a spinal inflammation, acute transverse myelitis, which consists of an inflammation in one or more adjacent segments. spinal cord. However, the independent expert panel that examined the matter established within days that this reaction was not related to the inoculation of the candidate vaccine. This experiment, explains di Lorenzo, “is actually carried out in double blindness: this means that neither the doctors nor the patients know which of the volunteers is given the candidate vaccine and which only placebo. Therefore, he concludes, the reaction Suspicious could also occurred in a volunteer who had taken the placebo and not the drug. “
[ad_2]
